Eyenovia to Report Third Quarter 2021 Results on Thursday, November 11
Eyenovia, Inc. (NASDAQ: EYEN) is set to announce its financial results for Q3 2021 on November 11, 2021, after market close. Following this, a conference call will be held at 5:00 PM ET to discuss the results and provide a business update. Participants can join the call by dialing 877-407-9039 domestically or 201-689-8470 internationally. A live webcast will also be available on Eyenovia's investor relations website. The event will be archived for one year.
- None.
- None.
Company to host an investor conference call and webcast at 5:00pm ET on that day
NEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, announced that the Company will release financial results for the third quarter ended September 30, 2021 on Thursday, November 11, 2021, after the market close. Following the release, Eyenovia management will host a conference call to review the financial and operating results and provide a business update.
The conference call is scheduled to begin at 5:00pm ET on Thursday, November 11, 2021. Participants should dial 877-407-9039 (domestic) or 201-689-8470 (international) with the conference code 13724626. A live webcast of the conference call will also be available on the investor relations page of the Company's corporate website at www.eyenovia.com.
After the live webcast, the event will be archived on Eyenovia’s website for one year.
About Eyenovia, Inc.
Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia and myopia progression. For more information, visit www.eyenovia.com.
The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.
Eyenovia Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.com
Eyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363
Eyenovia Media Contact:
Sam Choinski
Pazanga Health Communications
schoinski@pazangahealth.com
(603) 489-5964
FAQ
When will Eyenovia release its Q3 2021 financial results?
What time is the Eyenovia conference call?
How can I participate in Eyenovia's conference call?
Where can I find the webcast for Eyenovia's investor call?